Targeted drug delivery to ischemic heart with use of nanoparticulate carriers
Author:
Galagudza Michael,Korolev Dmitry,Sonin Dmitry,Postnov Viktor,Papayan Garry,Uskov Ivan,Belozertseva Anastasia,Shlyakhto Eugene
Abstract
PurposeClinical outcome in patients with ischemic heart disease can be significantly improved with the implementation of targeted drug delivery into the ischemic myocardium. The purpose of this paper is to review the data of recent literature and present original findings relevant to the problem of therapeutic heart targeting with use of nanoparticles.Design/methodology/approachFor literature review, a public‐domain database (Medline) was searched using a web‐based search engine (PubMed) and the following key words: “nanoparticles”, “nanocarriers”, and “targeted drug delivery”. Experimental approaches included fabrication of carbon and silica nanoparticles, their characterization and surface modification. The acute hemodynamic effects of nanoparticle formulation as well as nanoparticle biodistribution were studied on male Wistar rats.FindingsCarbon and silica nanoparticles are biocompatible materials that can be used as carriers for heart‐targeted drug delivery. Concepts of passive and active targeting can be applied to the development of targeted drug delivery to the ischemic myocardial cells.Originality/valueThe present paper is believed to be the first on ligand‐directed targeted drug delivery into the damaged myocardium.
Subject
Industrial and Manufacturing Engineering,Strategy and Management,Computer Science Applications,Control and Systems Engineering,Software
Reference25 articles.
1. Arias, J.L., Gallardo, V., Linares‐Molinero, F. and Delgado, A.V. (2006), “Preparation and characterization of carbonyl iron/poly(butylcyanoacrylate) core/shell nanoparticles”, Journal of Colloid and Interface Science, Vol. 299 No. 2, pp. 599‐607. 2. Beekman, K.W., Colevas, A.D., Cooney, K., Dipaola, R., Dunn, R.L., Gross, M., Keller, E.T., Pienta, K.J., Ryan, C.J., Smith, D. and Hussain, M. (2006), “Phase II evaluations of cilengitide in asymptomatic patients with androgen‐independent prostate cancer: scientific rationale and study design”, Clinical Genitourinary Cancer, Vol. 4 No. 4, pp. 299‐302. 3. Belova, V.S., Khekin, A.M., Postnov, V.N., Prusakov, V.E., Shilov, A.E. and Stepanova, M.L. (1992), “Oxidation of alkanes by dioxigen in the presence of an iron complex immobilized on modified silica: chemical model of methane monooxygenase”, Mendeleev Communications, Vol. 1, pp. 7‐8. 4. Cerchia, L., Giangrande, P.H., McNamara, J.O. and de Franciscis, V. (2009), “Cell‐specific aptamers for targeted therapies”, Methods in Molecular Biology, Vol. 535, pp. 59‐78. 5. Cheng, Y., Wang, J., Rao, T., He, X. and Xu, T. (2008), “Pharmaceutical applications of dendrimers: promising nanocarriers for drug delivery”, Frontiers in Bioscience, Vol. 13, pp. 1447‐71.
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|